[Management of virilization with an antiandrogen-containing contraceptive].
D000152:Acne Vulgaris / Q000188:drug therapy; D000328:Adult; D000726:Androgen Antagonists / Q000627:therapeutic use*; D003534:Cyproterone / Q000627:therapeutic use*; D017373:Cyproterone Acetate; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D004338:Drug Combinations / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D013739:Testosterone / Q000037:antagonists & inhibitors / Q000097:blood; D014770:Virilism / Q000097:blood / Q000188:drug therapy*
D000726:Androgen Antagonists; D004338:Drug Combinations; D013739:Testosterone; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination; D003534:Cyproterone
Androgenisatio tüneteinek befolyásolása antiandrogen tartalmú fogamzásgátlóval.